These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20374155)

  • 21. Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review.
    Solomon DA; Keitner GI; Ryan CE; Miller IW
    J Clin Psychopharmacol; 1998 Feb; 18(1):38-49. PubMed ID: 9472841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Open randomized comparative twelve-week study of lithium and valproate in manic episode].
    Mosolov SN; Kostiukova EG; Kapiletti SG; Belen'kaia DV; Shafarenko AA; Fedotov DD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):47-52. PubMed ID: 20032954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
    Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
    J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain.
    O'Donnell T; Rotzinger S; Nakashima TT; Hanstock CC; Ulrich M; Silverstone PH
    Eur Neuropsychopharmacol; 2003 May; 13(3):199-207. PubMed ID: 12729946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The high affinity inositol transport system--implications for the pathophysiology and treatment of bipolar disorder.
    van Calker D; Belmaker RH
    Bipolar Disord; 2000 Jun; 2(2):102-7. PubMed ID: 11252649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients.
    Silverstone PH; Asghar SJ; O'Donnell T; Ulrich M; Hanstock CC
    World J Biol Psychiatry; 2004 Jan; 5(1):38-44. PubMed ID: 15048634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inositol as an add-on treatment for bipolar depression.
    Chengappa KN; Levine J; Gershon S; Mallinger AG; Hardan A; Vagnucci A; Pollock B; Luther J; Buttenfield J; Verfaille S; Kupfer DJ
    Bipolar Disord; 2000 Mar; 2(1):47-55. PubMed ID: 11254020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium treatment effects on Myo-inositol in adolescents with bipolar depression.
    Patel NC; DelBello MP; Cecil KM; Adler CM; Bryan HS; Stanford KE; Strakowski SM
    Biol Psychiatry; 2006 Nov; 60(9):998-1004. PubMed ID: 17056394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of anticonvulsants in the aftermath of mania.
    Cookson J; Elliott B
    J Psychopharmacol; 2006 Mar; 20(2 Suppl):23-30. PubMed ID: 16551669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L; Llorca PM
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disodium valproate: new preparation. An alternative for acute mania after lithium failure or intolerance.
    Prescrire Int; 2001 Aug; 10(54):113-5. PubMed ID: 11718180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?
    Lagace DC; Eisch AJ
    Psychiatr Clin North Am; 2005 Jun; 28(2):399-414. PubMed ID: 15826739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal evaluation of reproductive function in women treated for bipolar disorder.
    Rasgon NL; Reynolds MF; Elman S; Saad M; Frye MA; Bauer M; Altshuler LL
    J Affect Disord; 2005 Dec; 89(1-3):217-25. PubMed ID: 16171873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Search for a common mechanism of mood stabilizers.
    Harwood AJ; Agam G
    Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of depakine chrono and lithium combination in the treatment of manic states].
    Aliev NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):49-50. PubMed ID: 14763259
    [No Abstract]   [Full Text] [Related]  

  • 39. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence.
    Shulman KI; Rochon P; Sykora K; Anderson G; Mamdani M; Bronskill S; Tran CT
    BMJ; 2003 May; 326(7396):960-1. PubMed ID: 12727769
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.
    Lan MJ; McLoughlin GA; Griffin JL; Tsang TM; Huang JT; Yuan P; Manji H; Holmes E; Bahn S
    Mol Psychiatry; 2009 Mar; 14(3):269-79. PubMed ID: 18256615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.